Concepedia
Statistics
Publications
22
Citations
1.3K
H-Index
18
Active since
2000
Affiliations
Bristol-Myers Squibb (United States)(Current)
University of Delaware
Bristol-Myers Squibb (Germany)
Cleveland Clinic
Lawrence J. Kennedy is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and medicinal chemistry.
Publications per year
2000–2021
Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
Lawrence J. Kennedy · Yearbook of Endocrinology · 2008 · 427 citations
Medicine, Pharmacology, Pharmacotherapy +17
Secondary Prevention of Macrovascular Events in Patients With Type 2 Diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macro Vascular Events): A Randomised Controlled Trial
Lawrence J. Kennedy, Jack L. Leahy · Yearbook of Endocrinology · 2006 · 101 citations
Medicine, Internal Medicine, Pharmacotherapy +14
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial
Jack L. Leahy, Lawrence J. Kennedy · Yearbook of Endocrinology · 2007 · 100 citations
Medicine, Endocrinology, Internal Medicine +12
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
Lawrence J. Kennedy · Yearbook of Endocrinology · 2008 · 92 citations
Medicine, Pharmacology, Pharmacotherapy +15
Enantiospecific and Regioselective Rhodium-Catalyzed Allylic Alkylation: Diastereoselective Approach to Quaternary Carbon Stereogenic Centers
P. Andrew Evans, Lawrence J. Kennedy · Organic Letters · 2000 · 65 citations
Natural Sciences, Chemistry, Catalysis +11
1–5 of 22